170 Efficacy and Safety of Dasotraline in Adults with Binge-Eating Disorder: A Randomized, Double-blind, Fixed-dose Trial.
| Author | |
|---|---|
| Abstract |
:
Dasotraline is a long-acting dopamine/norepinephrine reuptake inhibitor with a PK profile characterized by slow absorption and a t½ of 47-77 hours, permitting once-daily dosing. In a previous flexible dose study, dasotraline demonstrated significant efficacy in the treatment of binge-eating disorder (BED). The aim of this confirmatory fixed-dose study was to evaluate efficacy and safety of dasotraline in the treatment of patients with BED. |
| Year of Publication |
:
2020
|
| Journal |
:
CNS spectrums
|
| Volume |
:
25
|
| Issue |
:
2
|
| Number of Pages |
:
308-309
|
| ISSN Number |
:
1092-8529
|
| URL |
:
https://www.cambridge.org/core/product/identifier/S1092852920000863/type/journal_article
|
| DOI |
:
10.1017/S1092852920000863
|
| Short Title |
:
CNS Spectr
|
| Download citation |
